RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 21, 16:00
RVL Pharmaceuticals Gross Profit (TTM): 27.59M for June 30, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 27.59M |
| March 31, 2023 | 27.50M |
| December 31, 2022 | 40.26M |
| September 30, 2022 | 34.80M |
| June 30, 2022 | 28.35M |
| March 31, 2022 | 32.93M |
| December 31, 2021 | 13.88M |
| September 30, 2021 | 11.74M |
| June 30, 2021 | 35.26M |
| March 31, 2021 | 24.43M |
| December 31, 2020 | 52.23M |
| Date | Value |
|---|---|
| September 30, 2020 | 90.04M |
| June 30, 2020 | 103.62M |
| March 31, 2020 | 128.54M |
| December 31, 2019 | 128.40M |
| September 30, 2019 | 119.07M |
| June 30, 2019 | 113.91M |
| March 31, 2019 | 127.20M |
| December 31, 2018 | 125.52M |
| September 30, 2018 | 125.92M |
| June 30, 2018 | 125.21M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
11.74M
Minimum
Sep 2021
128.54M
Maximum
Mar 2020
59.56M
Average
35.26M
Median
Jun 2021
Gross Profit (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 7.753M |
| Palatin Technologies Inc | 5.700M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |